Patent Ductus Arteriosus: Clinical Trials

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	2	Terminated 2
Phase 2	1	Terminated 1

Follow Patent Ductus Arteriosus: new trials by email Literature Review of Patent Ductus Arteriosus trials Research Report on Patent Ductus Arteriosus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Acetaminophen vs Indomethacin in Treating hsPDA Indomethacin, Acetaminophen - Patent Ductus Arteriosus	Phase 3	Terminated	University of Tennessee	37	2016-06-01	2019-12-03
An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants Indomethacin - Patent Ductus Arteriosus	Phase 2 / Phase 3	Terminated	University of Calgary	9	2008-08-01	2016-08-18

Narrower conditions

Ductus Arteriosus, Patent (2)

Broader conditions

Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)

Interventions

Indomethacin (2)  ·  Acetaminophen (1)

Sponsors

University of Calgary (1)  ·  University of Tennessee (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Amuchou S Soraisham, MD, DM (1)

Results publications

PMID 18628265, PMID 21094951, PMID 22065264, PMID 23258386, PMID 24223740, PMID 24854626, PMID 25653299, PMID 26168357, PMID 26244949, PMID 26283668, PMID 26672023, PMID 4418268, PMID 6338474, PMID 6343572